MedTrace Logo

A Trial of Positively Smoke Free Group Therapy for HIV-infected Smokers

NCT02072772 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2025-10-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether Positively Smoke Free group therapy is more effective at promoting cessation than standard care.

Conditions

  • Tobacco Use in Persons Living With HIV

Interventions

BEHAVIORAL

Positively Smoke Free group treatment

See Arm Description

BEHAVIORAL

Standard Care

See Arm Description

Sponsors & Collaborators

  • Georgetown University

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Jonathan Shuter, MD · Montefiore Medical Center/Albert Einstein College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02072772 on ClinicalTrials.gov